Opko Health, Inc.
OPK- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000944809
No open-market purchases or sales by Opko Health, Inc. insiders were filed in the last 90 days; 222 institutions reported holding it in 13F filings for Q2 2026, worth $303.4M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Opko Health, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Opko Health, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Logal Adam | Sr. Vice President, CFO | 563,396 | Jul 28, 2026 | 1 |
| Rubin Steven D | Executive VP-Administration | 6,571,966 | Jul 28, 2026 | 1 |
| Medel Roger MD | Director | – | Jun 22, 2026 | 1 |
| Pfenniger Richard C Jr | Director | 325,000 | Jun 22, 2026 | 1 |
| Paganelli John A | Director | 394,340 | Jun 22, 2026 | 2 |
| Uppaluri Subbarao V | Director | – | Jun 22, 2026 | 2 |
| Yu Alice Lin-Tsing | Director | – | Jun 22, 2026 | 1 |
| Lachman Prem A | Director | – | Jun 22, 2026 | 1 |
| Frost Phillip MD Et Al | CEO & Chairman | 216,706,448Indirect | Nov 21, 2025 | 5 |
| Frost Gamma Investments Trust | 10% Owner | 216,706,448Indirect | Nov 21, 2025 | 5 |
| Hsiao Jane PH D | Vice Chairman & CTO | 28,499,880 | May 29, 2025 | 0 |
| Zerhouni Elias A. | Vice Chairman and President | 589,600 | May 29, 2025 | 0 |
| Nabel Gary J. | Chief Innovation Officer | 700,579 | May 29, 2025 | 0 |
| Krasno Richard M | Director | 103,333Indirect | Apr 23, 2025 | 0 |
| Borisy Alexis | Director | 312,612 | Jun 23, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 20, 2025 (view filing)6:10 PM ET | Nov 20 | Same day | Frost Phillip MD Et Al and 1 otherCEO & Chairman | PPurchase | +580.0K | $1.33 | +$771.3K | +0.3%216.1M after | 7 lots |
| Nov 21, 2025 (view filing)5:07 PM ET | Nov 21 | Same day | Frost Phillip MD Et Al and 1 otherCEO & Chairman | PPurchase | +580.0K | $1.33 | +$768.8K | +0.3%216.7M after | 5 lots |
| Mar 20, 2026 (view filing) | Mar 20 | Same day | Paganelli John ADirector | PPurchase | +10.0K | $1.14 | +$11.4K | +2.6%394.3K after |